Overview A Study of Efficacy and Safety With the Transdermal Contraceptive System. Status: Completed Trial end date: 1999-10-01 Target enrollment: Participant gender: Summary The purpose of the study is to evaluate the contraceptive efficacy, safety, cycle control, and compliance with the transdermal contraceptive system. Phase: Phase 3 Details Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Treatments: Contraceptive AgentsEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEthinyl EstradiolMoxifloxacinNorelgestrominNorgestimate, ethinyl estradiol drug combinationPolyestradiol phosphate